Cargando…
Calculus Bovis Sativus Improves Bile Acid Homeostasis via Farnesoid X Receptor-Mediated Signaling in Rats With Estrogen-Induced Cholestasis
Cholestatic diseases are characterized by toxic bile acid (BA) accumulation, and abnormal BA composition, which subsequently lead to liver injury. Biochemical synthetic Calculus Bovis Sativus (CBS) is derived from natural Calculus Bovis, a traditional Chinese medicine, which has been used to treat h...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6367682/ https://www.ncbi.nlm.nih.gov/pubmed/30774596 http://dx.doi.org/10.3389/fphar.2019.00048 |
_version_ | 1783393851977760768 |
---|---|
author | Xiang, Dong Yang, Jinyu Liu, Yanan He, Wenxi Zhang, Si Li, Xiping Zhang, Chenliang Liu, Dong |
author_facet | Xiang, Dong Yang, Jinyu Liu, Yanan He, Wenxi Zhang, Si Li, Xiping Zhang, Chenliang Liu, Dong |
author_sort | Xiang, Dong |
collection | PubMed |
description | Cholestatic diseases are characterized by toxic bile acid (BA) accumulation, and abnormal BA composition, which subsequently lead to liver injury. Biochemical synthetic Calculus Bovis Sativus (CBS) is derived from natural Calculus Bovis, a traditional Chinese medicine, which has been used to treat hepatic diseases for thousands of years. Although it has been shown that CBS administration to 17α-ethinylestradiol (EE)-induced cholestatic rats improves bile flow and liver injury, the involved underlying mechanism is largely unknown. In this study, we showed that CBS administration to EE-induced cholestatic rats significantly decreased serum and hepatic BA levels and reversed hepatic BA composition. DNA microarray analysis suggested that the critical pathways enriched by CBS treatment were bile secretion and primary BA synthesis. These findings led us to focus on the effects of CBS on regulating BA homeostasis, including BA transport, synthesis and metabolism. CBS enhanced hepatic BA secretion by inducing efflux transporter expression and inhibiting uptake transporter expression. Moreover, CBS reduced BA synthesis by repressing the expression of BA synthetic enzymes, CYP7A1 and CYP8B1, and increased BA metabolism by inducing the expression of metabolic enzymes, CYP3A2, CYP2B10, and SULT2A1. Mechanistic studies indicated that CBS increased protein expression and nuclear translocation of hepatic and intestinal farnesoid X receptor (FXR) to regulate the expression of these transporters and enzymes. We further demonstrated that beneficial effects of CBS administration on EE-induced cholestatic rats were significantly blocked by guggulsterone, a FXR antagonist. Therefore, CBS improved BA homeostasis through FXR-mediated signaling in estrogen-induced cholestatic rats. Together, these findings suggested that CBS might be a novel and potentially effective drug for the treatment of cholestasis. |
format | Online Article Text |
id | pubmed-6367682 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-63676822019-02-15 Calculus Bovis Sativus Improves Bile Acid Homeostasis via Farnesoid X Receptor-Mediated Signaling in Rats With Estrogen-Induced Cholestasis Xiang, Dong Yang, Jinyu Liu, Yanan He, Wenxi Zhang, Si Li, Xiping Zhang, Chenliang Liu, Dong Front Pharmacol Pharmacology Cholestatic diseases are characterized by toxic bile acid (BA) accumulation, and abnormal BA composition, which subsequently lead to liver injury. Biochemical synthetic Calculus Bovis Sativus (CBS) is derived from natural Calculus Bovis, a traditional Chinese medicine, which has been used to treat hepatic diseases for thousands of years. Although it has been shown that CBS administration to 17α-ethinylestradiol (EE)-induced cholestatic rats improves bile flow and liver injury, the involved underlying mechanism is largely unknown. In this study, we showed that CBS administration to EE-induced cholestatic rats significantly decreased serum and hepatic BA levels and reversed hepatic BA composition. DNA microarray analysis suggested that the critical pathways enriched by CBS treatment were bile secretion and primary BA synthesis. These findings led us to focus on the effects of CBS on regulating BA homeostasis, including BA transport, synthesis and metabolism. CBS enhanced hepatic BA secretion by inducing efflux transporter expression and inhibiting uptake transporter expression. Moreover, CBS reduced BA synthesis by repressing the expression of BA synthetic enzymes, CYP7A1 and CYP8B1, and increased BA metabolism by inducing the expression of metabolic enzymes, CYP3A2, CYP2B10, and SULT2A1. Mechanistic studies indicated that CBS increased protein expression and nuclear translocation of hepatic and intestinal farnesoid X receptor (FXR) to regulate the expression of these transporters and enzymes. We further demonstrated that beneficial effects of CBS administration on EE-induced cholestatic rats were significantly blocked by guggulsterone, a FXR antagonist. Therefore, CBS improved BA homeostasis through FXR-mediated signaling in estrogen-induced cholestatic rats. Together, these findings suggested that CBS might be a novel and potentially effective drug for the treatment of cholestasis. Frontiers Media S.A. 2019-02-01 /pmc/articles/PMC6367682/ /pubmed/30774596 http://dx.doi.org/10.3389/fphar.2019.00048 Text en Copyright © 2019 Xiang, Yang, Liu, He, Zhang, Li, Zhang and Liu. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Xiang, Dong Yang, Jinyu Liu, Yanan He, Wenxi Zhang, Si Li, Xiping Zhang, Chenliang Liu, Dong Calculus Bovis Sativus Improves Bile Acid Homeostasis via Farnesoid X Receptor-Mediated Signaling in Rats With Estrogen-Induced Cholestasis |
title | Calculus Bovis Sativus Improves Bile Acid Homeostasis via Farnesoid X Receptor-Mediated Signaling in Rats With Estrogen-Induced Cholestasis |
title_full | Calculus Bovis Sativus Improves Bile Acid Homeostasis via Farnesoid X Receptor-Mediated Signaling in Rats With Estrogen-Induced Cholestasis |
title_fullStr | Calculus Bovis Sativus Improves Bile Acid Homeostasis via Farnesoid X Receptor-Mediated Signaling in Rats With Estrogen-Induced Cholestasis |
title_full_unstemmed | Calculus Bovis Sativus Improves Bile Acid Homeostasis via Farnesoid X Receptor-Mediated Signaling in Rats With Estrogen-Induced Cholestasis |
title_short | Calculus Bovis Sativus Improves Bile Acid Homeostasis via Farnesoid X Receptor-Mediated Signaling in Rats With Estrogen-Induced Cholestasis |
title_sort | calculus bovis sativus improves bile acid homeostasis via farnesoid x receptor-mediated signaling in rats with estrogen-induced cholestasis |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6367682/ https://www.ncbi.nlm.nih.gov/pubmed/30774596 http://dx.doi.org/10.3389/fphar.2019.00048 |
work_keys_str_mv | AT xiangdong calculusbovissativusimprovesbileacidhomeostasisviafarnesoidxreceptormediatedsignalinginratswithestrogeninducedcholestasis AT yangjinyu calculusbovissativusimprovesbileacidhomeostasisviafarnesoidxreceptormediatedsignalinginratswithestrogeninducedcholestasis AT liuyanan calculusbovissativusimprovesbileacidhomeostasisviafarnesoidxreceptormediatedsignalinginratswithestrogeninducedcholestasis AT hewenxi calculusbovissativusimprovesbileacidhomeostasisviafarnesoidxreceptormediatedsignalinginratswithestrogeninducedcholestasis AT zhangsi calculusbovissativusimprovesbileacidhomeostasisviafarnesoidxreceptormediatedsignalinginratswithestrogeninducedcholestasis AT lixiping calculusbovissativusimprovesbileacidhomeostasisviafarnesoidxreceptormediatedsignalinginratswithestrogeninducedcholestasis AT zhangchenliang calculusbovissativusimprovesbileacidhomeostasisviafarnesoidxreceptormediatedsignalinginratswithestrogeninducedcholestasis AT liudong calculusbovissativusimprovesbileacidhomeostasisviafarnesoidxreceptormediatedsignalinginratswithestrogeninducedcholestasis |